Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aclaris, Akamis, Alx, ARS, Atai, Bpgbio, Biodexa, Briacell, Clarity, Cybin, Disc, Galectin, Hanchorbio, Kashiv, Kineta, Nexcella, PDS.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acurx, Ascendis, Caliway, Cassava, Horizon, Immix, Mirum, Moleculin, Nexcella, Novartis, PDS, Pharmnovo, Pneumagen, Trevena.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Ascletis, Astrazeneca, Callidtas, Immunogenesis, Ionis, JCR, Nanobiotix, Scisparc, Structure, Verastem, Vericel.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Alligator, Ascletis, Biolinerx, Bionomics, Cantargia, Crystal, Edesa, Elicio, Harpoon, Immunogenesis, Imunon, J&J, Mabwell, Sagimet, Synthekine.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adcentrx, Adverum, Alligator, Alto, Biosenic, Candel, Cantex, Cardiff, Gracell, Kallyope, Remegen, Sensei, Small, Smart Immune, Unity, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinogen, Allergy, AM-Pharma, Armata, Ascletis, Axial, Biovie, Candel, Cantex, Cue, Drug Farm, Edgewise, Elpiscience, Immunovant, Inozyme, Ionis, Lumos, Mesentech, NMD, Omega, OS Therapies, Pliant, Recce, Small, Soleno, Synaptogenix, Taysha Gene, Tiziana, Xbiotech, YS.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4SC, Ascendis, Clene, Escient, Lantern, Nervgen, Novartis, Nykode, Reviva, Zucara.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bioinvent, Bristol Myers Squibb, Daiichi Sankyo, Innate, Merck & Co., Recce, Seagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antengene, Apnimed, Cybin, Cymabay, Entrada, Gilgamesh, Lipella, Moleculin, Newamsterdam, Protara, Revolo, Sellas, Travere.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affamed, Alzecure, Asieris, Humanetics, Immpact, Peptilogics, Photocure, Protara, Regulus, Relmada, Seelos, Syndevrx, Vir.